FDA Drug recall D-1167-2014
Venlafaxine Hydrochloride, Extended Release Capsules, 150 mg, UD-100 Tablets per Box (10 x 10), Rx Only, Manufactured by: Teva Pharmaceutic…
- FDA Drug
- Class III
- terminated
- Published 2014-03-26
On 2014-03-26 the FDA classified a Class III recall of Venlafaxine Hydrochloride, Extended Release Capsules, 150 mg, UD-100 Tablets per Box (10 x 10), Rx Only, Manufactured by: Teva Pharmaceutic… by Mckesson Packaging Services, citing failed Dissolution Specification: Out of Specification dissolution results at 12 month interval.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1167-2014 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2014-03-03 |
| Published | 2014-03-26 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Mckesson Packaging Services |
| Distribution | US |
Product
Venlafaxine Hydrochloride, Extended Release Capsules, 150 mg, UD-100 Tablets per Box (10 x 10), Rx Only, Manufactured by: Teva Pharmaceuticals USA, 1090 Horsham Rd, North Wales, PA 19454, NDC 63739-0512-10
Reason
Failed Dissolution Specification: Out of Specification dissolution results at 12 month interval.
Identifiers
| code_info | Lot #: 91357 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1167-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.